TSE:WLLW Willow Biosciences (WLLW) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Willow Biosciences Stock (TSE:WLLW) Get Willow Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day RangeC$0.17▼C$0.1752-Week Range N/AVolume59,500 shsAverage Volume626,457 shsMarket CapitalizationC$24.62 millionP/E RatioN/ADividend Yield7.35%Price TargetN/AConsensus RatingN/A Company Overview Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada. Read More Receive WLLW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Willow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WLLW Stock News HeadlinesWILLOW BIOSCIENCES INC AT XTSE (WLLW.NE)June 10, 2026 | finance.yahoo.comWILLOW BIOSCIENCES INC. ANNOUNCES COMPLETION OF TRANSFORMATIVE RECAPITALIZATION TRANSACTIONS TO FORM ATLAS ENERGY CORP.June 19, 2025 | finance.yahoo.comReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.October 11 at 1:00 AM | Base Camp Trading (Ad)WILLOW BIOSCIENCES INC. ANNOUNCES CONDITIONAL ACCEPTANCE OF TSX VENTURE EXCHANGE TO LIST PURSUANT TO THE TSXV SANDBOXJune 18, 2025 | stockhouse.comWillow Biosciences Inc.: Willow Biosciences Reports First Quarter 2025 Financial ResultsMay 13, 2025 | finanznachrichten.deWILLOW BIOSCIENCES INC. RECEIVES FIRM COMMITMENTS OF $30.0 MILLION UNDER PREVIOUSLY ANNOUNCED RECAPITALIZATION FINANCINGMay 9, 2025 | finance.yahoo.comWillow Biosciences Inc.: Willow Biosciences Announces Annual General And Special Meeting Voting ResultsApril 26, 2025 | finanznachrichten.deWillow Biosciences reports significant loss and imminent closureMarch 27, 2025 | msn.comSee More Headlines WLLW Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Willow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Willow Biosciences investors own include Canopy Growth (CGC), Dynavax Technologies (DVAX), Lightspeed Commerce (LSPD), VEON (VEON), BlackBerry (BB) and Industry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolTSE:WLLW CIKN/A Webwww.willowbio.com Phone403 910 5140FaxN/AEmployees19Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$7.92 million Net Margins-132.75% Pretax MarginN/A Return on Equity-422.31% Return on Assets-74.79% Debt Debt-to-Equity Ratio-390.30 Current Ratio0.33 Quick Ratio19.71 Sales & Book Value Annual SalesC$2.94 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.83 Book ValueC$0.00 per share Price / BookN/AMiscellaneous Outstanding Shares144,847,000Free FloatN/AMarket CapC$24.62 million OptionableNot Optionable Beta1.13 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (TSE:WLLW) was last updated on 8/22/2025 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Willow Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Willow Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
